Concepedia

Douglas W. Grosenbach

DW

Statistics

Publications

37

Citations

3.4K

H-Index

30

Active since

1995

Affiliations

Siga Technologies (United States)(Current)

National Cancer Institute

National Institutes of Health

Oregon State University

Center for Cancer Research

Douglas W. Grosenbach is an author at Siga Technologies (United States) specializing in medicine, immunology, and virology.

Top concepts

Publications per year

1995–2023

37

Publications

37

Oral Tecovirimat for the Treatment of Smallpox

Douglas W. Grosenbach, Kady M. Honeychurch, Eric A. Rose et al. · New England Journal of Medicine · 2018 · 403 citations · Full text

Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas

John L. Marshall, James L. Gulley, Philip M. Arlen et al. · Journal of Clinical Oncology · 2004 · 296 citations

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

Philip M. Arlen, James L. Gulley, Catherine Parker et al. · Clinical Cancer Research · 2006 · 291 citations · Full text

IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity

Mary Litzinger, Romaine I. Fernando, Tyler J. Curiel et al. · Blood · 2007 · 184 citations · Full text

A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Chelsea M. Byrd, Dongcheng Dai, Douglas W. Grosenbach et al. · Antimicrobial Agents and Chemotherapy · 2012 · 163 citations · Full text

Rows per page

1–5 of 37